Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. (Q46167485)
Jump to navigation
Jump to search
scientific article published on 18 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. |
scientific article published on 18 June 2012 |
Statements
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression (English)
Eva Karlsson
Ulla M Wilking
Ulla Johansson
Elisabet Kerstin Lidbrink
Thomas Hatschek
Lambert Skoog